Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy

被引:0
作者
ZHANG Dingqi [1 ,2 ]
MU Yongping [1 ,2 ]
XU Ying [1 ,2 ]
CHEN Jiamei [1 ,2 ]
LIU Ping [1 ,2 ,3 ]
LIU Wei [1 ,2 ]
机构
[1] Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
[2] Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
[3] Institute of Interdisciplinary Complex Research,Shanghai University of Traditional Chinese
关键词
D O I
暂无
中图分类号
R269 [现代医学外科疾病];
学科分类号
摘要
This article presented an overview of the therapeutic effects of Chinese medicine(CM) preparations for promoting blood circulation and removing blood stasis for patients with portal vein thrombosis(PVT) after splenectomy.Based on published clinical researches of CM preparations for PVT after splenectomy in patients with cirrhotic portal hypertension(CPH), this paper evaluated the incidence of PVT,and explored potential active components and mechanisms of CM preparations.Safflower Yellow Injection,Danshen Injection,Danhong Injection,and Compound Danshen Dropping Pill achieved good curative effect alone or combined with anticoagulant therapy.In addition,Compound Biejia Ruangan Tablet and Anluo Huaxian Pill can also significantly improve the hemodynamic disorders of portal vein system in patients with cirrhosis.Considering the role of CM preparations in ameliorating the incidence of PVT after splenectomy in patients with CPH,we suggested that future research should provide more attention to CM alone or CM combined with anticoagulant for cirrhosis with PVT.
引用
收藏
页码:855 / 863
页数:9
相关论文
共 52 条
  • [1] 基于网络药理学探讨丹红注射液成分-抗血栓靶点的相互作用
    李泮霖
    刘宏
    廖弈秋
    李沛波
    姚宏亮
    苏薇薇
    [J]. 中山大学学报(自然科学版), 2018, 57 (04) : 121 - 127
  • [2] 三七植物化学成分及药理作用研究进展
    杨娟
    袁一怔
    尉广飞
    张连娟
    徐江
    董林林
    [J]. 世界科学技术-中医药现代化, 2017, 19 (10) : 1641 - 1647
  • [3] 丹参酮ⅡA对心血管系统药理作用的研究进展
    曹慧敏
    吴瑾
    贾连群
    杨关林
    [J]. 世界中医药, 2017, 12 (07) : 1718 - 1722
  • [4] 肝硬化门脉高压患者肝动脉与门静脉病理变化分析
    张浩
    李波
    [J]. 重庆医学, 2017, 46 (20) : 2767 - 2769+2773
  • [5] 银杏叶提取物的药理作用及其临床应用研究进展
    张鹏飞
    廖丽君
    邓祯
    谭玉萍
    [J]. 辽宁中医杂志, 2017, 44 (02) : 426 - 429
  • [6] 基于Meta分析的血栓通注射剂治疗急性脑梗死临床评价研究
    王茜
    吴嘉瑞
    张丹
    王凯欢
    张冰
    [J]. 药物流行病学杂志, 2016, 25 (10) : 616 - 622
  • [7] 基于Meta分析的舒血宁注射液治疗脑梗死临床评价研究
    谭迪
    吴嘉瑞
    刘施
    张冰
    [J]. 药物流行病学杂志, 2016, 25 (08) : 492 - 498
  • [8] 复方鳖甲软肝片与恩替卡韦联合应用对代偿期乙型肝炎肝硬化患者血浆D-二聚体的影响
    刘颖翰
    林佃相
    石栓柱
    古玉茹
    冯敬国
    孔素华
    温占平
    [J]. 中西医结合肝病杂志, 2016, 26 (02) : 84 - 85
  • [9] 低分子肝素联合香丹注射液预防妇科恶性肿瘤腹腔镜手术后静脉血栓性疾病
    申沛
    林耀蕙
    郭伟平
    朱芳芳
    王军
    刘勇战
    [J]. 实用医药杂志, 2015, 32 (07) : 607 - 609
  • [10] 阿德福韦酯联合复方鳖甲软肝片治疗慢性乙型肝炎患者临床疗效观察
    朱琼香
    李小丹
    [J]. 实用肝脏病杂志, 2015, 18 (03) : 258 - 261